COVID-19, the OSTP Nelson Memo, the Cancer Moonshot, and more—in the past three years, STM publishing and government decision-making have significantly overlapped. But how these decisions are reached—and how scholarly publishers try to influence these decisions, both before and after implementation—is an opaque process. This session brings together representatives from scholarly publishing's government relations and public affairs teams. We'll review the possibilities, realities, and limits of advocacy work; the key individuals, agencies, and committees of the US federal government that oversee the sciences, arts, and humanities; and the policy positions and legislation affecting publishers, authors, and researchers in these spaces.
